NJR (NJR)

$5.5B
Market Cap
17.0
P/E Ratio
0.58
Beta
3.48%
Dividend Yield
Piotroski 6/9Altman Z 1.4 DistressBeneish M -2.44 CleanROIC−WACC -0.4%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9, Altman Z 1.4.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The company exhibits a robust capital allocation profile with an ROIC of 6.5%, though the DuPont decomposition reveals that equity returns are primarily driven by financial leverage (3.17x) rather than operational efficiency or margin expansion alone, as asset turnover remains modest at 0.27x. Despite this leverage-heavy structure, profitability metrics remain compelling with a net margin of 16.5% and gross margins expanding to 35.7%, supported by double-digit revenue growth of 13.4%. Fundamental integrity appears strong given the high Piotroski F-Score of 6/9 and a negative Beneish M-Score of -2.44, suggesting low earnings manipulation risk alongside consistent financial health indicators.

Valuation sits at a current P/E multiple of 17.0x, which requires contextualization against historical averages and sector peers to determine if the market is pricing in aggressive future growth or acknowledging potential headwinds. While the implied growth rate from revenue figures supports premium multiples, the reliance on leverage for ROE generation introduces sensitivity to interest rate fluctuations that could compress returns if asset turnover fails to improve. The combination of solid margins and growth suggests the stock may be fairly valued only if operational efficiency can scale alongside top-line expansion without eroding the current margin profile.

A notable divergence emerges in insider behavior, with $625,120 in net selling over the last 90 days, which contrasts sharply with the otherwise positive fundamental signals and low manipulation risk scores. This insider outflow warrants scrutiny as a potential signal of management caution regarding future execution or valuation levels, potentially offsetting some confidence derived from the high F-Score and strong revenue trajectory. The interplay between these divergent data points—strong fundamentals versus active insider distribution—creates an ambiguous risk-reward landscape that necessitates careful monitoring of subsequent quarterly results to confirm whether current selling pressure is justified by unseen operational challenges or purely valuation concerns.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
1.4
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.44
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

35.7%
Gross Margin
16.5%
Net Margin
6.5%
ROIC
6.8%
WACC
ROIC − WACC Spread: -0.4%— Negative spread.
+13.4%
Revenue Growth (YoY)
+15.8%
Earnings Growth (YoY)
-239.7M
Free Cash Flow

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

16.5%
Net Profit Margin
NI ÷ Revenue
×
0.27x
Asset Turnover
Revenue ÷ Assets
×
3.17x
Equity Multiplier
Assets ÷ Equity
=
14.0%
Return on Equity
⚠️ High equity multiplier — ROE is being amplified by leverage, not operational excellence.

Balance Sheet Health

2.17x
Debt / Equity
0.73x
Current Ratio
4.3x
Interest Coverage
4.4x
Net Debt / EBITDA
-2.73%
FCF Yield
743.9M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
$-625,120
Net Selling
0
Buy Transactions
2
Sale Transactions
2026-03-19REICH RICHARDSold 1/8 qtrsSale$288,743
2026-03-16BEL ROBERTOSold 2/8 qtrsSale$336,377
2026-01-21DEGRAFFENREIDT JAMES H JRGrant$140,936
2026-01-21TAYLOR SHARON C.Grant$140,936
2026-01-21YARDLEY WILLIAM TURNERGrant$73,634

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $1.62
Act: $1.78
+9.8%
Q3
✓ Beat
Est: $-0.03
Act: $0.06
+274.1%
Q2
✗ Miss
Est: $0.19
Act: $0.16
-16.9%
Q1
✓ Beat
Est: $1.00
Act: $1.17
+17.4%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

16.0
Forward P/E
PEG Ratio
2.31
Price/Book
554862
Avg Volume
$55.49
52W High
$43.46
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$588M
Tracked Passive Exposure
8
ETFs Holding NJR
0.11%
Avg Weight in ETFs
$542B
Total ETF AUM

When investors buy or sell ETFs like DVY or VPU, the fund manager is mechanically forced to buy or sell NJR shares regardless of NJR's individual fundamentals. We estimate $588M of passive capital is structurally linked to NJR through 8 tracked ETFs. Passive flows have a limited but growing influence on NJR's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in NJR to visualize passive redemption contagion across ETFs and collateral stocks.

NJR Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
NJREpicenterVBETFVYMETFVXFETFNEEHigh RiskSOHigh RiskDUKHigh RiskCEGMed RiskAEPHigh Risk
NJR Price Drop (%)0

If NJR (NJR) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies NextEra Energy Inc. (NEE) as the most exposed collateral stock, sharing 1 ETFs with NJR. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 13 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

NJR Ownership Dynamics

Ticker
NJR

Float lock-up computed from 13 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

NJR Capital Efficiency

How efficiently does NJR convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$-239,729,000
EBITDA
$744M
FCF Conversion
-32%
Reinvestment Rate
132%
-32% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
6.5%
ROIC − WACC Spread
-0.4%

NJR converts -32% of its EBITDA into free cash flow, negative FCF conversion — the company is consuming cash faster than it generates EBITDA, which is unsustainable long-term. The 132% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-0.4%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1319$56.96$1,082.24
2026-05-1219$55.82$1,060.58
2026-05-111$55.55$55.55
2026-05-081$55.53$55.53
2026-04-151,374$56.09$77,067.66
2026-04-072,000$55.84$111,680
2026-04-062,000$55.96$111,920
2026-03-31217$55.44$12,030.48
2026-03-264$54.12$216.48
2026-03-203$53.79$161.37
2026-03-18200$54.23$10,846
2026-03-12979$53.91$52,777.89
2026-03-02186$54.24$10,088.64
2026-02-171,234$54.23$66,919.82
2026-02-0229$49.48$1,434.92
2025-12-2251$46.31$2,361.81
2025-12-021$47.25$47.25
2025-11-28104$47.88$4,979.52
2025-11-26104$47.88$4,979.52
2025-11-254$48.29$193.16
2025-11-242$48.83$97.66
2025-11-212$48.04$96.08
2025-11-1728$46.62$1,305.36
2025-11-0730$45.19$1,355.7
2025-10-14304$45.13$13,719.52
2025-10-103$46.01$138.03

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare NJR to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.